NuwellisNUWE
About: Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Employees: 38
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
4.32% more ownership
Funds ownership: 3.16% [Q1] → 7.48% (+4.32%) [Q2]
18% less funds holding
Funds holding: 11 [Q1] → 9 (-2) [Q2]
44% less capital invested
Capital invested by funds: $129K [Q1] → $72.1K (-$56.5K) [Q2]
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Research analyst outlook
We haven’t received any recent analyst ratings for NUWE.
Financial journalist opinion
Based on 9 articles about NUWE published over the past 30 days









